Pimozide-induced depression in men who stutter

Journal of Clinical Psychiatry

Volumn 58, Issue 10, 1997, Pages 433-436

  Bloch, Miki ^a   Stager, Sheila ^b   Braun, Allen ^b   Calis, Karim A ^c   Turcasso, Nanette M ^c   Grothe, Dale R ^c   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PIMOZIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; HUMAN; MALE; PRIORITY JOURNAL; SPEECH; STUTTERING;

EID: 0030724646     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n1004     Document Type: Article

References (25)

1. Mann JJ, Kapur S. A dopaminergic hypothesis of major depression. Clin Neuropharmacol 1995;18:S57-S65
2. Wise RA. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 1982;5:39-87
3. Badelow B, Muller P, Frick U, et al. Depressive syndromes in schizophrenic patients under neuroleptic therapy. Eur Arch Psychiatry Clin Neurosci 1992;241:291-295
4. Harrow M, Yonan CA, Sands JR, et al. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr Bull 1994;20: 327-338
5. Hirsch SR, Jolley AG, Barnes TRE, et al. Dysphoric depressive symptoms in chronic schizophrenia. Schizophr Bull 1989;2:259-264
6. Halstead SM, Bames TRE, Speller JC. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry 1994;164:177-183
7. Van Putten T, May PRA. "Akinetic depression" in schizophrenia. Arch Gen Psychiatry 1978;35:1101-1107
8. Anderson BG, Reker D, Cooper TB. Prolonged adverse effects of haloperidol in normal subjects. N Engl J Med 1981;305:643-644
9. Hollister LE. Neuroleptic dysphoria: so what's new? Biol Psychiatry 1992;31:531-537
10. King DJ, Burke M, Lucas RA. Antipsychotic drug-induced dysphoria. Br J Psychiatry 1995;167:480-482
11. Bowers MB, Astrachan BM. Depression in acute schizophrenic psychosis. Am J Psychiatry 1967;123:976-979
12. Sims SG, Rifkin A, Reardon GT, et al. Course-related depressive syndromes in schizophrenia. Am J Psychiatry 1984;141:1254-1257
13. McGlashan TH, Carpenter WT. Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 1976;33:231-239
14. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia-Lifetime Version. New York, NY: Biometric Research, New York State Psychiatric Institute; 1975
15. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
16. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
17. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970
18. Bloch M, Stager SV, Braun A, et al. Severe psychiatric symptoms associates with paroxetine withdrawal. Lancet 1995;346:57
19. Wells PG, Malcolm MT. Controlled trial of the treatment of 36 stutterers. Br J Psychiatry 1971;119:603-604
20. Swift WJ, Swift EW, Arellano M. Haloperidol as a treatment for adult stuttering. Compr Psychiatry 1975;16:61-67
21. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454
22. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neural Neurosurg Psychiatry 1986;49:381-389
23. Mayeux R. Depression in the patient with Parkinson's disease. J Clin Psychiatry 1990;51(7, suppl):20-23
24. Maricle RA, Nutt JG, Valentine RJ, et al. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 1995;45:1757-1760
25. Newcomer JW, Miller LS, Faustman WO, et al. Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria. Br J Psychiatry 1994;164:834-838